Patents by Inventor Derrick W. Reed

Derrick W. Reed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8332033
    Abstract: Systems and methods are provided for use by implantable medical devices equipped to deliver multi-site left ventricular (MSLV) pacing. Sequential MSLV is associated with a relatively long post-ventricular atrial blanking (PVAB) period that might limit the detection of pathologic rapid organized atrial tachycardias (OAT). In one example, sequential MSLV cardiac resynchronization therapy (CRT) pacing is delivered within a tracking mode. A possible atrial tachycardia is detected based on the atrial rate exceeding an atrial tachycardia assessment rate (ATAR) threshold. The device then switches to either single-site LV pacing or simultaneous MSLV pacing, thereby effectively shortening the PVAB to detect additional atrial events that might otherwise be obscured, and thereby permitting the device to more reliably distinguish OATs (such as atrial flutter) from sinus tachycardia.
    Type: Grant
    Filed: May 16, 2011
    Date of Patent: December 11, 2012
    Assignee: Pacesetter, Inc.
    Inventors: Derrick W. Reed, Rohan A. More, Heidi Hellman, Eliot L. Ostrow, Paul A. Levine
  • Publication number: 20110319953
    Abstract: Systems and methods are provided for use by implantable medical devices equipped to deliver multi-site left ventricular (MSLV) pacing. Sequential MSLV is associated with a relatively long post-ventricular atrial blanking (PVAB) period that might limit the detection of pathologic rapid organized atrial tachycardias (OAT). In one example, sequential MSLV cardiac resynchronization therapy (CRT) pacing is delivered within a tracking mode. A possible atrial tachycardia is detected based on the atrial rate exceeding an atrial tachycardia assessment rate (ATAR) threshold. The device then switches to either single-site LV pacing or simultaneous MSLV pacing, thereby effectively shortening the PVAB to detect additional atrial events that might otherwise be obscured, and thereby permitting the device to more reliably distinguish OATs (such as atrial flutter) from sinus tachycardia.
    Type: Application
    Filed: May 16, 2011
    Publication date: December 29, 2011
    Applicant: PACESETTER, INC.
    Inventors: Derrick W. Reed, Rohan A. More, Heidi Hellman, Eliot L. Ostrow, Paul A. Levine
  • Patent number: 7917194
    Abstract: Conditions resulting from acute decompensation such as pulmonary edema may be indicated based on analysis of respiration signals. In some embodiments a respiration signal is derived from an intracardiac electrogram (“IEGM”) signal. In some embodiments one or more non-rate-based parameters are derived from a detected respiration signal to identify a pulmonary edema condition. In some embodiments a warning may be generated or therapy administered to a patient in response to an indication of pulmonary edema.
    Type: Grant
    Filed: November 15, 2006
    Date of Patent: March 29, 2011
    Assignee: Pacesetter, Inc.
    Inventors: Derrick W. Reed, Yougandh Chitre